5.25
+0.27
+(5.42%)
As of 8:05:16 AM GMT+2. Market Open.
Loading Chart for 6IB.SG
- Previous Close
4.98 - Open
5.25 - Bid 5.45 x --
- Ask 5.60 x --
- Day's Range
5.25 - 5.25 - 52 Week Range
3.64 - 6.10 - Volume
0 - Avg. Volume
568 - Market Cap (intraday)
6.716B - Beta (5Y Monthly) --
- PE Ratio (TTM)
-- - EPS (TTM)
-- - Earnings Date Mar 26, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Recent News: 6IB.SG
View MorePerformance Overview: 6IB.SG
Trailing total returns as of 4/11/2025, which may include dividends or other distributions. Benchmark is HANG SENG INDEX (^HSI) .
YTD Return
6IB.SG
20.41%
HANG SENG INDEX (^HSI)
4.26%
1-Year Return
6IB.SG
19.86%
HANG SENG INDEX (^HSI)
22.34%
3-Year Return
6IB.SG
62.04%
HANG SENG INDEX (^HSI)
1.38%
5-Year Return
6IB.SG
30.60%
HANG SENG INDEX (^HSI)
13.93%
Compare To: 6IB.SG
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: 6IB.SG
View MoreValuation Measures
As of 4/10/2025
Market Cap
8.37B
Enterprise Value
7.74B
Trailing P/E
--
Forward P/E
147.06
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
6.92
Price/Book (mrq)
4.98
Enterprise Value/Revenue
6.62
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
--
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
--
Diluted EPS (ttm)
--
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--
Research Analysis: 6IB.SG
View MoreCompany Insights: 6IB.SG
Research Reports: 6IB.SG
View MorePeople Also Watch
6IB.F Innovent Biologics, Inc.
5.30
+7.72%
2L9.F Blueprint Medicines Corporation
69.86
+1.57%
4DN.MU Denali Therapeutics Inc.
11.30
-2.67%
A71.F Ascendis Pharma A/S
128.00
+4.07%
8SJ.F Shanghai Junshi Biosciences Co., Ltd.
1.5500
-7.19%
49B.SG BeiGene, Ltd.
15.76
+2.04%
UP0.F Ultragenyx Pharmaceutical Inc.
29.40
-3.92%
9LB.F Legend Biotech Corporation
28.40
+0.71%
4RY.F Akeso, Inc.
9.65
+14.88%
4DN.F Denali Therapeutics Inc.
11.24
-3.19%
49BA.F BeiGene, Ltd.
204.00
+2.00%
HDP1.F Arrowhead Pharmaceuticals, Inc.
9.89
-1.10%
DR6.F ACADIA Pharmaceuticals Inc.
12.54
-7.01%
AM6.F Amicus Therapeutics, Inc.
5.75
-6.50%
2CL.F BridgeBio Pharma, Inc.
28.80
+2.82%
RV7.F Halozyme Therapeutics, Inc.
51.42
-5.48%